Hospira, Inc. recalled 15,750 vials of Sodium Bicarbonate Injection on August 4, 2025. The recall stems from a lack of assurance of sterility. Consumers and healthcare providers must stop using the product immediately.
Lack of Assurance of Sterility.
Consumers and healthcare providers should stop using this product immediately. Contact PFIZER INC or your healthcare provider for guidance. Notification method: Letter
The recalled product is Sodium Bicarbonate Injection, USP, 50mEq/50 mL, with Lot #: LH2671 and an expiration date of November 30, 2026. The product was distributed nationwide in the U.S.
The recall is due to a lack of assurance of sterility, which poses a high risk of contamination. This can lead to serious health issues for patients receiving the injection.
No specific incidents have been reported related to this recall. However, the potential for serious health risks remains.
Stop using the product immediately. Contact Pfizer Inc. or your healthcare provider for guidance on next steps.
For further information, consumers can visit the FDA recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0591-2025.
Abiomed issued a recall for 10,153 Automated Impella Controllers on October 1, 2025. The devices face potential cybersecurity vulnerabilities related to their operating system. Healthcare providers and patients should stop using these devices immediately.
Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.
AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.